Patient Perspectives on Digital Interventions to Manage Heart Failure Medications: The VITAL-HF Pilot.

Marc D Samsky¹, Renee Leverty², James M Gray³, Alexandra Davis⁴, Brett Fisher⁴, Ashul Govil⁴, Tom Stanis⁴, Adam D DeVore^2,3

¹Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.

²The Duke Clinical Research Institute, Durham, NC 27710, USA.

³Duke Heart Center, Duke University School of Medicine, Durham, NC 27710, USA.

⁴Story Health, Cupertino, CA 95014, USA.

PubMed PMC DOI PDF

Abstract

Use of guideline-directed medical therapy (GDMT) for treatment of heart failure with reduced ejection fraction (HFrEF) remains unacceptably low. The purpose of this study was to determine whether a digital health tool can augment GDMT for patients with HFrEF. Participants ≥ 18 years old with symptomatic HFrEF (left ventricular ejection fraction ≤ 40%) and with access to a mobile phone with interne…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.